Ioforminol (GE-145; AN-113111) as an iv contrast agent (Phase 2) « New Drug...
Ioforminol (GE-145; AN-113111) as an iv contrast agent (Phase 2) « New Drug Approvals: 'via Blog this'
View ArticleClik here to view.
Sun Pharma has bought Ranbaxy for $4 billion to create the world’s...
Dilip sanghvi, sun pharma promoterThe move will make the company the largest pharma firm in India, while Daiichi Sankyo – majority owner of Ranbaxy – will become the second largest shareholder in Sun...
View ArticleCabotegravir, GSK 744 IN PHASE 2 FOR HIV INFECTION « New Drug Approvals
Cabotegravir, GSK 744 IN PHASE 2 FOR HIV INFECTION « New Drug Approvals: "Cabotegravir, GSK...
View ArticleCabotegravir, GSK 744 IN PHASE 2 FOR HIV INFECTION « New Drug Approvals
Cabotegravir, GSK 744 IN PHASE 2 FOR HIV INFECTION « New Drug Approvals: "Cabotegravir, GSK...
View ArticleDoravirine, MK-1439 reverse transcriptase inhibitor In Phase 3 for treatment...
Doravirine, MK-1439 reverse transcriptase inhibitor In Phase 3 for treatment of HIV-1 infection « New Drug Approvals: 'via Blog this'
View ArticleNERATINIB, HKI 272, ..Puma presents positive results from phase II trial of...
NERATINIB, HKI 272, ..Puma presents positive results from phase II trial of its investigational drug PB272 « New Drug Approvals: 'via Blog this'
View ArticleAmbit Biosciences announces Phase 3 trial comparing quizartinib as...
Ambit Biosciences announces Phase 3 trial comparing quizartinib as monotherapy to chemotherapy regimens in relapsed/refractory acute myeloid leukemia (AML) patients with the FMS-like tyrosine kinase-3...
View ArticleElbasvir, MK 8742 ……….Anti-Hepatitis C Virus Drug in phase 2 « New Drug...
Elbasvir, MK 8742 ……….Anti-Hepatitis C Virus Drug in phase 2 « New Drug Approvals: 'via Blog this'
View ArticleCDRI planning to launch Phase-1 trials on 2 candidate drugs to fight malaria,...
CDRI planning to launch Phase-1 trials on 2 candidate drugs to fight malaria, diabetes « New Drug Approvals: 'via Blog this'
View ArticleCarcerand for Molecular encapsulation …Drug Delivery « New Drug Approvals
Carcerand for Molecular encapsulation …Drug Delivery « New Drug Approvals: 'via Blog this'
View ArticleCarcerand for Molecular encapsulation …Drug Delivery « New Drug Approvals
Carcerand for Molecular encapsulation …Drug Delivery « New Drug Approvals: 'via Blog this'
View ArticleTelapristone acetate « New Drug Approvals
Telapristone acetate « New Drug Approvals: 'via Blog this'
View ArticleTelapristone acetate « New Drug Approvals
Telapristone acetate « New Drug Approvals: 'via Blog this'
View ArticleGlenmark Pharmaceuticals Ltd. through its Swiss Subsidiary receives USD 5 Mn....
Glenmark Pharmaceuticals Ltd. through its Swiss Subsidiary receives USD 5 Mn. as milestone fee payment from Sanofi « New Drug Approvals: 'via Blog this'
View ArticleSotagliflozin, LX 4211 in phase 2 For type 1, 2diabetes « New Drug Approvals
Sotagliflozin, LX 4211 in phase 2 For type 1, 2diabetes « New Drug Approvals: 'via Blog this'
View ArticleCarbohydrate Derivatives and Glycomimetic Compounds in Established and...
Carbohydrate Derivatives and Glycomimetic Compounds in Established and Investigational Therapies of Type 2 Diabetes Mellitus « New Drug Approvals: 'via Blog this'
View ArticleOMARIGLIPTIN. MK 3102 IN PHASE 3 FOR TYPE 2 DIABETES « New Drug Approvals
OMARIGLIPTIN. MK 3102 IN PHASE 3 FOR TYPE 2 DIABETES « New Drug Approvals: 'via Blog this'
View ArticleClik here to view.
A novel approach to identify molecular binding to the influenza virus H5N1:...
http://pubs.rsc.org/en/Content/ArticleLanding/2014/MD/C3MD00272A?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+rss%2FMD+%28RSC+-+Med.+Chem.+Commun.+latest+articles%29#!divAbstractI...
View ArticleNovel Oxazolidinone Antibacterial Candidate FYL-67...
Novel Oxazolidinone Antibacterial Candidate FYL-67 …..(S)-N-((3-(3-Fluoro-4-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)phenyl)-2-oxo-oxazolidin-5-yl)methyl)acetamide « New Drug Approvals: 'via Blog this'
View ArticleEvacetrapib, LY2484595 for Treatment of high cholesterol and preventing...
Evacetrapib, LY2484595 for Treatment of high cholesterol and preventing cardiac events « New Drug Approvals: 'via Blog this'
View Article